On 2026-11-02, PEDaily reported that Guoke Tanmei had recently completed a Pre-A round. It said the proceeds would be used to expand capacity for high-performance porous carbon and build a supercapacitor production line in Bozhou. Those disclosed uses concern materials and downstream devices, respectively. For an unlisted technology company in China preparing to raise funds, moving from materials into devices raises a specific budgeting question. If it sends the same approved batch to its own line, which scheduled payment from an outside customer can still arrive on time?

Manufacturing company Harbinger provides international context. On 2026-11-05, Harbinger announced a Series D round. It said the proceeds would help it continue increasing manufacturing capacity for its medium-duty platform, among other uses. This announcement illustrates how building manufacturing capacity can figure in a funding plan and offers no basis for inferring the company's production or collections schedule. Youdu Capital provides financial advisory services solely for the domestic financing of unlisted Chinese technology companies and does not provide cross-border financial services. The overseas information is for background only.

Consider a hypothetical case unrelated to the companies' actual operations. A materials manufacturer already sells to outside customers and is preparing a pilot run of its own devices. Both plans look feasible when discussed separately. Sales expects to ship a batch to a customer, and production expects to draw materials of the same specification from the same inventory. Putting the plans side by side reveals that both rely on the same batch already cleared by quality control. The warehouse count is correct, yet the company cannot meet both the external and internal delivery dates as scheduled.

The first effect shows up in production scheduling. Once the batch goes to internal production, the company needs another approved batch to fill the sales order. It might be able to produce a replacement before the customer's receiving window, or it might miss the window. Even if similar material is on hand, differences in specification, release status or what the customer accepts can rule it out as a substitute. The fundraising forecast needs to identify which batch can serve as a replacement, when it becomes available and whether the original shipment date is still feasible.

The second effect shows up in the cash forecast. The company may assign an internal value to materials issued to production, but no outside party pays the company on the day it makes that transfer. If the shipment to the outside customer is delayed, the expected cash may move to the next collection window. Payments for outside purchases and testing needed to continue making the devices may still come due as planned. Cash from the new product depends on the outside customer's acceptance and payment arrangements. The devices may be expected to earn more per unit, but those expected earnings cannot pay the bills in the intervening months.

Two weekly forecasts side by side make the difference easier to explain. One prioritizes the existing shipment to the outside customer and schedules the device pilot using the approved volume that actually remains. The other begins the pilot as planned and reschedules the affected sales shipment. Both start with the same cash balance and known operating expenses and include documented payments to and receipts from outside parties. Comparing each week's balance and the low point shows whether the business is paying more, collecting later or facing both changes at once.

Some sales shipments can be filled from another batch and the payments may still arrive on time. In that case there is no reason to show a loss. Other orders may require a revised delivery date after the customer window closes, or the company may no longer be able to fill them. Model those cases separately. Record sales leads as possibilities until they become orders, without treating them as cash the company would otherwise have received. If the cash forecast already includes an outside payment for a replacement batch, adding the internal transfer value would count a new cash outflow that never occurred.

For fundraising materials, the team can walk through an example using actual operating records. Pick a batch that both sales and production need to confirm, and record its quantity, release status, each team's latest usable date, and any substitute batch with evidence of its release status. Sales can confirm which scheduled shipments and receipts the change affects. Production can identify when the pilot requires additional outside spending, and finance can update the cash balance on the same weekly schedule. If the basis for a figure changes, keep the earlier and later versions so the team can explain which cash flow moved.

Over the next three to six months, if the device pilot remains concentrated in a few delivery windows, the company can set aside enough approved material for existing sales and schedule a manageable pilot using the remainder. For each batch, it can record when the devices are ready for customer acceptance and whether sales receipts came in on schedule. If the pilot keeps using more material than planned and the sales shipments have to wait for later batches, the next cash plan should show both pilot spending and deferred receipts and reconsider how much production can run in parallel. If substitute batches have consistently cleared on schedule and actual receipts support the original forecast, the company has evidence to narrow that cash stress scenario.

Another possible outcome is that material allocation leaves existing sales intact, but the devices get held up at final testing. Any additional funding need should then be explained by the later production stage and its documented expenses. Conversely, if the devices have been delivered but the expected payments for materials sales have yet to resume, check the two collection schedules separately. Each update should use the same batch and timing assumptions for both production and finance so funding providers can see what created the shortfall and under which conditions it may narrow.

Allocating a batch looks like a production decision, and it can also determine which cash receipt comes first. A fundraising plan should show how each allocation changes actual payments, receipts and available cash and identify which inputs remain conditional. This is a method for preparing operating forecasts, informed by public material. It makes no promises about fundraising or operating outcomes and provides no specific investment, legal or tax advice.

Sources 投资界:国科炭美完成数亿元Pre-A轮融资 (2026-11-02) https://www.pedaily.cn/first/189433.shtml Harbinger Motors: Series D funding announcement (2026-11-05) https://harbingermotors.com/newsroom/harbinger-raises-240-million-series-d-funding-round/

Content note: This article was drafted with AI assistance and reviewed through an independent AI process, using the listed public sources. It contains no original interviews, and no first-hand testing of the products, services or methods discussed was conducted. Checking public sources is not a field investigation or first-hand experience.